Search Within

Ronald A Ghossein

  1. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (23)
  2. Meeting Abstract (6)
  3. Editorial (1)
Groups
  1. Department of Pathology and Laboratory Medicine (30)
  2. Molecular Imaging and Therapy Service (30)
  3. Radiology, Department of (30)
  4. Department of Medicine (24)
  5. Division of Subspecialty Medicine (23)
  6. Endocrinology (23)

More Groups

People
  1. Robert Tuttle (18)
  2. Heiko Schoder (15)
  3. Steven Larson (14)
  4. Alan Ho (13)
  5. James Fagin (13)
  6. Ravinder Grewal (12)

More People

Years
  1. 2024 (3)
  2. 2023 (3)
  3. 2022 (4)
  4. 2021 (1)
  5. 2020 (2)
  6. 2019 (2)

More Years

Publications
  1. Journal of Clinical Oncology (5)
  2. European Journal of Nuclear Medicine and Molecular Imaging (4)
  3. Journal of Clinical Endocrinology and Metabolism (4)
  4. Thyroid (3)
  5. Annals of Surgical Oncology (2)
  6. Cancer (2)

More Publications

Publishers
  1. Springer (7)
  2. American Society of Clinical Oncology (5)
  3. Oxford University Press (4)
  4. American Association for Cancer Research (3)
  5. Mary Ann Liebert, Inc (3)
  6. Wiley Blackwell (2)

More Publishers

Results (30)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • [(18)F]TFB PET/CT misses intense [(124)I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancer
    Journal Article

    Backhaus, P.; Pentlow, K. S.; Ho, A. L.; Mauguen, A.; Fagin, J. A.; Pillarsetty, N. V. K.; Lyashchenko, S. K.; Burnazi, E.; Ghossein, R. A.; Chhabra, S.; more...
    EJNMMI Research (2024)

    Fulltext@MSK | Save
  • DNA mutational and copy number variation profiling of primary craniofacial osteosarcomas by next-generation sequencing
    Journal Article

    Zhu, G. G.; Lu, C.; Petrovic, I.; Nafa, K.; Chen, W.; Syed, A.; Rana, S.; Klein, M. J.; Huang, S.; Wang, L.; more...
    Head and Neck Pathology (2024)

    Fulltext@MSK | Save
  • Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: Overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs
    Editorial

    Bodei, L.; Tuttle, R. M.; Grewal, R. K.; Mauguen, A.; Augensen, F.; Abusamra, M.; Mahajan, S.; Jayaprakasam, V. S.; Osborne, J. R.; Haque, S.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • Prospective comparison of F-18-TFB and I-124 PET/CT in metastatic thyroid cancer
    Meeting Abstract

    Backhaus, P.; Pentlow, K.; Ho, A. L.; Mauguen, A.; Fagin, J. A.; Pillarsetty, N. V. K.; Lyashchenko, S. K.; Burnazi, E.; Ghossein, R. A.; Chhabra, S.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): A regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients
    Journal Article

    Mauguen, A.; Grewal, R. K.; Augensen, F.; Abusamra, M.; Mahajan, S.; Jayaprakasam, V. S.; Osborne, J.; Haque, S.; Wong, B. Z. Y.; Ghossein, R. A.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Genomic and transcriptomic characteristics of metastatic thyroid cancers with exceptional responses to radioactive iodine therapy
    Journal Article

    Boucai, L.; Saqcena, M.; Kuo, F.; Grewal, R. K.; Socci, N.; Knauf, J. A.; Krishnamoorthy, G. P.; Ryder, M.; Ho, A. L.; Ghossein, R. A.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446)
    Meeting Abstract

    Burman, B.; Tuttle, R. M.; Grewal, R. K.; Sherman, E. J.; Baxi, S. S.; Boucai, L.; Sabra, M.; Fish, S.; Pentlow, K. S.; Haque, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinicopathologic and prognostic features of pediatric follicular cell-derived thyroid carcinomas: A retrospective study of 222 patients
    Journal Article

    Saliba, M.; Alzumaili, B. A.; Katabi, N.; Dogan, S.; Tuttle, R. M.; Zoltan, A.; Pandit-Taskar, N.; Xu, B.; Ghossein, R. A.
    American Journal of Surgical Pathology (2022)

    Fulltext@MSK | Save
  • Enhancing radioiodine incorporation in BRAF-mutant, radioiodine-refractory thyroid cancers with vemurafenib and the anti-ERBB3 monoclonal antibody CDX-3379: Results of a pilot clinical trial
    Journal Article

    Tchekmedyian, V.; Dunn, L.; Sherman, E.; Baxi, S. S.; Grewal, R. K.; Larson, S. M.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M. M.; more...
    Thyroid (2022)

    Fulltext@MSK | Save
  • Targeting the mTOR pathway in hurthle cell carcinoma results in potent antitumor activity
    Journal Article

    Dong, Y.; Gong, Y.; Kuo, F.; Makarov, V.; Reznik, E.; Nanjangud, G. J.; Aras, O.; Zhao, H.; Qu, R.; Fagin, J. A.; more...
    Molecular Cancer Therapeutics (2022)

    Fulltext@MSK | Save